As House Democrats advance a commonsense plan to lower prescription drug prices, Washington Republicans side with big drug companies
Late last night, the Ways and Means Committee passed the “Elijah Eugene Cummings Lower Drug Prices Now Act” (H.R. 3) to lower the cost of prescription drugs for families. Specifically, the bill allows Medicare to negotiate with drug companies for lower prescription drug prices and reverses unjustified price gouging on thousands of medications like insulin.
But instead of supporting this commonsense bill to lower drug prices, Republicans in Washington once again stood with big drug companies and voted “no.” This comes after Republicans handed out billions to those same wealthy drug makers just last year.
The nonpartisan Congressional Budget Office has already stated the bill would lower domestic drug prices and save at least $345 billion for the American people. This legislation will save a family of four approximately $1,920 per year.
“Seniors and working families need relief from out of control prescription drug costs, but Washington Republicans just voted to stand with big drug companies over hardworking families in communities across the country,” said DCCC Spokesperson Cole Leiter. “While House Democrats continue to put the priorities of Americans first, Washington Republicans once again showed their true colors: they care more about padding the pockets of the prescription drug manufacturers that lobbied them to oppose this critical legislation.”
Time and again, Americans say that lowering the cost of prescription drugs is a top priority and the contrast between the different priorities of Democrats and Republicans couldn’t be clearer.
###
Similar releases were sent to districts across the country.